Trial Profile

A Randomized Phase III Trial Comparing Trabectedin (Yondelis) to the Best Supportive Care in Patients With Advanced Soft Tissue Sarcoma

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 05 May 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Trabectedin (Primary) ; Dexamethasone
Indications Leiomyosarcoma; Liposarcoma; Soft tissue sarcoma; Synovial sarcoma
Focus Therapeutic Use
Acronyms TSAR

Most Recent Events

28 Apr 2021 Results published in the Annals of Oncology
14 Aug 2018 Status changed from active, no longer recruiting to completed.
05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com